stockrowBioCardia, Inc. (BCDA) vs Bolt Biotherapeutics, Inc. (BOLT)
- BioCardia, Inc. BCDA 0.87 −2.25%
- Bolt Biotherapeutics, Inc. BOLT 6.52 +2.19%
BioCardia, Inc. and Bolt Biotherapeutics, Inc. are both Biotechnology companies. BioCardia, Inc. and Bolt Biotherapeutics, Inc. are of similar size ($13.5M and $12.3M). Bolt Biotherapeutics, Inc. grew revenue faster over the last twelve months: 12.8% against 0.71%. BioCardia, Inc. has the higher net margin (0.00% vs −611.5%) and the higher return on invested capital (0.00% vs −143.8%). Across the 17 metrics below, Bolt Biotherapeutics, Inc. leads on 9 and BioCardia, Inc. on 8.
Valuation
Profitability
| Metric | BCDA | BOLT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | 0.00% | (654.53%) | 0.00% |
| Net margin | 0.00% | (611.47%) | 0.00% |
| Free cash flow margin | 0.00% | (655.72%) | 0.00% |
| Return on equity | (1,803.19%) | (111.65%) | (51.96%) |
| Return on assets | (214.47%) | (49.62%) | (46.06%) |
| Return on invested capital | 0.00% | (143.75%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack